The tiers and dimensions of evasion of the type i interferon response by human cytomegalovirus

Journal of Molecular Biology

Volumn 425, Issue 24, 2013, Pages 4857-4871

  Amsler, Lisi ^a   Verweij, Marieke C ^a   Defilippis, Victor R ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

cytomegalovirus; immune evasion; innate immunity; interferon

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYCLOOXYGENASE 2; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 6; PROTEIN KINASE; RETINOIC ACID; STAT1 PROTEIN; STAT2 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIVIRAL ACTIVITY; AUTOPHOSPHORYLATION; CELL MATURATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; DNA REPLICATION; DNA RESPONSIVE ELEMENT; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOME SIZE; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNE EVASION; IMMUNE RESPONSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; VIRUS GENOME; VIRUS REPLICATION;

CYTOMEGALOVIRUS; HERPESVIRIDAE; HUMAN HERPESVIRUS 5;

EID: 84888014733     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2013.08.023     Document Type: Review

References (160)

1. N. Stern-Ginossar, B. Weisburd, A. Michalski, V.T. Le, M.Y. Hein, S.X. Huang, M. Ma, B. Shen, S.B. Qian, H. Hengel, M. Mann, N.T. Ingolia, and J.S. Weissman Decoding human cytomegalovirus Science 338 2012 1088 1093
2. F. Grey, A. Antoniewicz, E. Allen, J. Saugstad, A. McShea, J.C. Carrington, and J. Nelson Identification and characterization of human cytomegalovirus-encoded microRNAs J Virol 79 2005 12095 12099
3. M.J. Cannon, D.S. Schmid, and T.B. Hyde Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection Rev Med Virol 20 2010 202 213
4. S. Manicklal, V.C. Emery, T. Lazzarotto, S.B. Boppana, and R.K. Gupta The silent global burden of congenital cytomegalovirus Clin Microbiol Rev 26 2013 86 102
5. C. Steininger, E. Puchhammer-Stockl, and T. Popow-Kraupp Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART) J Clin Virol 37 2006 1 9
6. I. Yust, Z. Fox, M. Burke, A. Johnson, D. Turner, A. Mocroft, C. Katlama, B. Ledergerber, P. Reiss, and O. Kirk Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994-2001 Eur J Clin Microbiol Infect Dis 23 2004 550 559
7. M.T. Grattan, C.E. Moreno-Cabral, V.A. Starnes, P.E. Oyer, E.B. Stinson, and N.E. Shumway Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis JAMA 261 1989 3561 3566
8. S. Pouria, O.I. State, W. Wong, and B.M. Hendry CMV infection is associated with transplant renal artery stenosis QJM 91 1998 185 189
9. P.D. Sorlie, F.J. Nieto, E. Adam, A.R. Folsom, E. Shahar, and M. Massing A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study Arch Intern Med 160 2000 2027 2032
10. L. Harkins, A.L. Volk, M. Samanta, I. Mikolaenko, W.J. Britt, K.I. Bland, and C.S. Cobbs Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer Lancet 360 2002 1557 1563
11. A.E. Aiello, M. Haan, L. Blythe, K. Moore, J.M. Gonzalez, and W. Jagust The influence of latent viral infection on rate of cognitive decline over 4 years J Am Geriatr Soc 54 2006 1046 1054
12. H.N. Schmaltz, L.P. Fried, Q.L. Xue, J. Walston, S.X. Leng, and R.D. Semba Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women J Am Geriatr Soc 53 2005 747 754
13. N. Tavalai, and T. Stamminger New insights into the role of the subnuclear structure ND10 for viral infection Biochim Biophys Acta 1783 2008 2207 2221
14. M.K. Isaacson, L.K. Juckem, and T. Compton Virus entry and innate immune activation Curr Top Microbiol Immunol 325 2008 85 100
15. D.F. Bratcher, N. Bourne, F.J. Bravo, M.R. Schleiss, M. Slaoui, M.G. Myers, and D.I. Bernstein Effect of passive antibody on congenital cytomegalovirus infection in guinea pigs J Infect Dis 172 1995 944 950
16. S. Jonjic, I. Pavic, B. Polic, I. Crnkovic, P. Lucin, and U.H. Koszinowski Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus J Exp Med 179 1994 1713 1717
17. T. Crough, and R. Khanna Immunobiology of human cytomegalovirus: from bench to bedside Clin Microbiol Rev 22 2009 76 98 [Table of Contents]
18. A.W. Sylwester, B.L. Mitchell, J.B. Edgar, C. Taormina, C. Pelte, F. Ruchti, P.R. Sleath, K.H. Grabstein, N.A. Hosken, F. Kern, J.A. Nelson, and L.J. Picker Broadly targeted human cytomegalovirus-specific CD4 + and CD8 + T cells dominate the memory compartments of exposed subjects J Exp Med 202 2005 673 685
19. M. Sester, U. Sester, B. Gartner, B. Kubuschok, M. Girndt, A. Meyerhans, and H. Kohler Sustained high frequencies of specific CD4 T cells restricted to a single persistent virus J Virol 76 2002 3748 3755
20. V. Noriega, V. Redmann, T. Gardner, and D. Tortorella Diverse immune evasion strategies by human cytomegalovirus Immunol Res 54 2012 140 151
21. J. Banchereau, V. Pascual, and A.K. Palucka Autoimmunity through cytokine-induced dendritic cell activation Immunity 20 2004 539 550
22. R.B. Mailliard, Y.I. Son, R. Redlinger, P.T. Coates, A. Giermasz, P.A. Morel, W.J. Storkus, and P. Kalinski Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function J Immunol 171 2003 2366 2373
23. A. Le Bon, and D.F. Tough Links between innate and adaptive immunity via type I interferon Curr Opin Immunol 14 2002 432 436
24. T. Seya, J. Kasamatsu, M. Azuma, H. Shime, and M. Matsumoto Natural killer cell activation secondary to innate pattern sensing J Innate Immun 3 2011 264 273
25. M.G. Tovey, C. Lallemand, and G. Thyphronitis Adjuvant activity of type I interferons Biol Chem 389 2008 541 545
26. C.A. Biron, and L. Brossay NK cells and NKT cells in innate defense against viral infections Curr Opin Immunol 13 2001 458 464
27. D. Bussfeld, M. Nain, P. Hofmann, D. Gemsa, and H. Sprenger Selective induction of the monocyte-attracting chemokines MCP-1 and IP-10 in vesicular stomatitis virus-infected human monocytes J Interferon Cytokine Res 20 2000 615 621
28. S.L. Pogue, B.T. Preston, J. Stalder, C.R. Bebbington, and P.M. Cardarelli The receptor for type I IFNs is highly expressed on peripheral blood B cells and monocytes and mediates a distinct profile of differentiation and activation of these cells J Interferon Cytokine Res 24 2004 131 139
29. E. Sakamoto, F. Hato, T. Kato, C. Sakamoto, M. Akahori, M. Hino, and S. Kitagawa Type I and type II interferons delay human neutrophil apoptosis via activation of STAT3 and up-regulation of cellular inhibitor of apoptosis 2 J Leukoc Biol 78 2005 301 309
30. T.P. Salazar-Mather, and K.L. Hokeness Calling in the troops: regulation of inflammatory cell trafficking through innate cytokine/chemokine networks Viral Immunol 16 2003 291 306
31. B.X. Wang, and E.N. Fish The yin and yang of viruses and interferons Trends Immunol 33 2012 190 197
32. S.V. Kotenko, G. Gallagher, V.V. Baurin, A. Lewis-Antes, M. Shen, N.K. Shah, J.A. Langer, F. Sheikh, H. Dickensheets, and R.P. Donnelly IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex Nat Immunol 4 2003 69 77
33. P. Sheppard, W. Kindsvogel, W. Xu, K. Henderson, S. Schlutsmeyer, T.E. Whitmore, R. Kuestner, U. Garrigues, C. Birks, J. Roraback, C. Ostrander, D. Dong, J. Shin, S. Presnell, B. Fox, B. Haldeman, E. Cooper, D. Taft, T. Gilbert, F.J. Grant, M. Tackett, W. Krivan, G. McKnight, C. Clegg, D. Foster, and K.M. Klucher IL-28, IL-29 and their class II cytokine receptor IL-28R Nat Immunol 4 2003 63 68
34. R.M. Presti, J.L. Pollock, A.J. Dal Canto, A.K. O'Guin, and H.W. Virgin Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels J Exp Med 188 1998 577 588
35. S. Dupuis, E. Jouanguy, S. Al-Hajjar, C. Fieschi, I.Z. Al-Mohsen, S. Al-Jumaah, K. Yang, A. Chapgier, C. Eidenschenk, P. Eid, A. Al Ghonaium, H. Tufenkeji, H. Frayha, S. Al-Gazlan, H. Al-Rayes, R.D. Schreiber, I. Gresser, and J.L. Casanova Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency Nat Genet 33 2003 388 391
36. D. Vairo, L. Tassone, G. Tabellini, N. Tamassia, S. Gasperini, F. Bazzoni, A. Plebani, F. Porta, L.D. Notarangelo, S. Parolini, S. Giliani, and R. Badolato Severe impairment of IFN-gamma and IFN-alpha responses in cells of a patient with a novel STAT1 splicing mutation Blood 118 2011 1806 1817
37. A. Chapgier, R.F. Wynn, E. Jouanguy, O. Filipe-Santos, S. Zhang, J. Feinberg, K. Hawkins, J.L. Casanova, and P.D. Arkwright Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo J Immunol 176 2006 5078 5083
38. Y. Wen, and P. Liu Interferon successfully inhibited refractory cytomegalovirus infection and resulted in CD4 + T-cells increase in a patient with AIDS HIV Clin Trials 12 2011 118 120
39. G. Emodi, R. O'Reilly, A. Muller, L.K. Everson, U. Binswanger, and M. Just Effect of human exogenous leukocyte interferon in cytomegalovirus infections J Infect Dis 133 Suppl. 1976 A199 A204
40. V.T. Le, M. Trilling, M. Wilborn, H. Hengel, and A. Zimmermann Human cytomegalovirus interferes with signal transducer and activator of transcription (STAT) 2 protein stability and tyrosine phosphorylation J Gen Virol 89 2008 2416 2426
41. L.A. Glasgow, J.B. Hanshaw, T.C. Merigan, and J.K. Petralli Interferon and cytomegalovirus in vivo and in vitro Proc Soc Exp Biol Med 125 1967 843 849
42. A.R. Holmes, L. Rasmussen, and T.C. Merigan Factors affecting the interferon sensitivity of human cytomegalovirus Intervirology 9 1978 48 55
43. B. Sainz Jr., H.L. Lamarca, R.F. Garry, and C.A. Morris Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma Virol J 2 2005 14
44. M. Iwata, J. Vieira, M. Byrne, H. Horton, and B. Torok-Storb Interleukin-1 (IL-1) inhibits growth of cytomegalovirus in human marrow stromal cells: inhibition is reversed upon removal of IL-1 Blood 94 1999 572 578
45. N. Grandvaux, M.J. Servant, B. tenOever, G.C. Sen, S. Balachandran, G.N. Barber, R. Lin, and J. Hiscott Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes J Virol 76 2002 5532 5539
46. E.P. Browne, B. Wing, D. Coleman, and T. Shenk Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs J Virol 75 2001 12319 12330
47. K.A. Simmen, J. Singh, B.G. Luukkonen, M. Lopper, A. Bittner, N.E. Miller, M.R. Jackson, T. Compton, and K. Fruh Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B Proc Natl Acad Sci U S A 98 2001 7140 7145
48. D. Abate, S. Watanabe, and E. Mocarski Major human cytomegalovirus structural protein pp 65 (ppUL83) prevents interferon response factor 3 activation in the interferon response J Virol 78 2004 10995 11006
49. V.R. DeFilippis, B. Robinson, T.M. Keck, S.G. Hansen, J.A. Nelson, and K. Früh Interferon regulatory factor 3 is necessary for induction of antiviral genes during human cytomegalovirus infection J Virol 80 2006 1032 1037
50. H. Zhu, J.P. Cong, and T. Shenk Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: induction of interferon-responsive RNAs Proc Natl Acad Sci U S A 94 1997 13985 13990
51. F.X. Zhu, S.M. King, E.J. Smith, D.E. Levy, and Y. Yuan A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation Proc Natl Acad Sci U S A 99 2002 5573 5578
52. V.R. DeFilippis, and K.J. Früh Rhesus cytomegalovirus particles prevent activation of interferon regulatory factor 3 J Virol 79 2005 6419 6431
53. R. Lin, R.S. Noyce, S.E. Collins, R.D. Everett, and K.L. Mossman The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes J Virol 78 2004 1675 1684
54. K. Shuai, and B. Liu Regulation of JAK-STAT signalling in the immune system Nat Rev Immunol 3 2003 900 911
55. Y. Zhou, S. Wang, A. Gobl, and K. Oberg Interferon alpha induction of Stat1 and Stat2 and their prognostic significance in carcinoid tumors Oncology 60 2001 330 338
56. S.D. Der, A. Zhou, B.R. Williams, and R.H. Silverman Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays Proc Natl Acad Sci U S A 95 1998 15623 15628
57. H. Cheon, and G.R. Stark Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes Proc Natl Acad Sci U S A 106 2009 9373 9378
58. B. Testoni, C. Vollenkle, F. Guerrieri, S. Gerbal-Chaloin, G. Blandino, and M. Levrero Chromatin dynamics of gene activation and repression in response to interferon alpha (IFN(alpha)) reveal new roles for phosphorylated and unphosphorylated forms of the transcription factor STAT2 J Biol Chem 286 2011 20217 20227
59. T.A. Kraus, J.F. Lau, J.P. Parisien, and C.M. Horvath A hybrid IRF9-STAT2 protein recapitulates interferon-stimulated gene expression and antiviral response J Biol Chem 278 2003 13033 13038
60. J.E. Grundy, J. Trapman, J.E. Allan, G.R. Shellam, and C.J. Melief Evidence for a protective role of interferon in resistance to murine cytomegalovirus and its control by non-H-2-linked genes Infect Immun 37 1982 143 150
61. K. Schneider, A. Loewendorf, C. De Trez, J. Fulton, A. Rhode, H. Shumway, S. Ha, G. Patterson, K. Pfeffer, S.A. Nedospasov, C.F. Ware, and C.A. Benedict Lymphotoxin-mediated crosstalk between B cells and splenic stroma promotes the initial type I interferon response to cytomegalovirus Cell Host Microbe 3 2008 67 76
62. M.T. Lun, G. Lorino, A. Gaeta, P. Dessy, P. Cipriani, P. Filadoro, M.R. Capobianchi, P. Di Marco, and C. Mancini In vitro interferon production: induction in human leukocytes after exposure to cytomegalovirus antigens Microbiologica 9 1986 399 404
63. A.N. van den Pol, M.D. Robek, P.K. Ghosh, K. Ozduman, P. Bandi, M.D. Whim, and G. Wollmann Cytomegalovirus induces interferon-stimulated gene expression and is attenuated by interferon in the developing brain J Virol 81 2007 332 348
64. S.P. Gravel, and M.J. Servant Roles of an IkappaB kinase-related pathway in human cytomegalovirus-infected vascular smooth muscle cells: a molecular link in pathogen-induced proatherosclerotic conditions J Biol Chem 280 2005 7477 7486
65. J. Renneson, B. Dutta, S. Goriely, B. Danis, S. Lecomte, J.F. Laes, Z. Tabi, M. Goldman, and A. Marchant IL-12 and type I IFN response of neonatal myeloid DC to human CMV infection Eur J Immunol 39 2009 2789 2799
66. E.O. Kvale, J. Dalgaard, F. Lund-Johansen, H. Rollag, L. Farkas, K. Midtvedt, F.L. Jahnsen, J.E. Brinchmann, and J. Olweus CD11c + dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection Blood 107 2006 2022 2029
67. D.D. Sedmak, S. Chaiwiriyakul, D.A. Knight, and W.J. Waldmann The role of interferon beta in human cytomegalovirus-mediated inhibition of HLA DR induction on endothelial cells Arch Virol 140 1995 111 126
68. K.A. Horan, K. Hansen, M.R. Jakobsen, C.K. Holm, S. Soby, L. Unterholzner, M. Thompson, J.A. West, M.B. Iversen, S.B. Rasmussen, S. Ellermann-Eriksen, E. Kurt-Jones, S. Landolfo, B. Damania, J. Melchjorsen, A.G. Bowie, K.A. Fitzgerald, and S.R. Paludan Proteasomal degradation of herpes simplex virus capsids in macrophages releases DNA to the cytosol for recognition by DNA sensors J Immunol 190 2013 2311 2319
69. U. Nagarajan Induction and function of IFNbeta during viral and bacterial infection Crit Rev Immunol 31 2011 459 474
70. W.X. Sin, P. Li, J.P. Yeong, and K.C. Chin Activation and regulation of interferon-beta in immune responses Immunol Res 53 2012 25 40
71. K.W. Boehme, J. Singh, S.T. Perry, and T. Compton Human cytomegalovirus elicits a coordinated cellular antiviral response via envelope glycoprotein B J Virol 78 2004 1202 1211
72. A.D. Yurochko, T.F. Kowalik, S.M. Huong, and E.S. Huang Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters J Virol 69 1995 5391 5400
73. L. Navarro, K. Mowen, S. Rodems, B. Weaver, N. Reich, D. Spector, and M. David Cytomegalovirus activates interferon immediate-early response gene expression and an interferon regulatory factor 3-containing interferon- stimulated response element-binding complex Mol Cell Biol 18 1998 3796 3802
74. C.M. Preston, A.N. Harman, and M.J. Nicholl Activation of interferon response factor-3 in human cells infected with herpes simplex virus type 1 or human cytomegalovirus J Virol 75 2001 8909 8916
75. A.D. Yurochko, E.S. Hwang, L. Rasmussen, S. Keay, L. Pereira, and E.S. Huang The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection J Virol 71 1997 5051 5059
76. E.P. Browne, and T. Shenk Human cytomegalovirus UL83-coded pp 65 virion protein inhibits antiviral gene expression in infected cells Proc Natl Acad Sci U S A 100 2003 11439 11444
77. R.T. Taylor, and W.A. Bresnahan Human cytomegalovirus IE86 attenuates virus- and tumor necrosis factor alpha-induced NFkappaB-dependent gene expression J Virol 80 2006 10763 10771
78. M.R. Thompson, J.J. Kaminski, E.A. Kurt-Jones, and K.A. Fitzgerald Pattern recognition receptors and the innate immune response to viral infection Viruses 3 2011 920 940
79. T. Compton, E.A. Kurt-Jones, K.W. Boehme, J. Belko, E. Latz, D.T. Golenbock, and R.W. Finberg Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2 J Virol 77 2003 4588 4596
80. L.K. Juckem, K.W. Boehme, A.L. Feire, and T. Compton Differential initiation of innate immune responses induced by human cytomegalovirus entry into fibroblast cells J Immunol 180 2008 4965 4977
81. K.W. Boehme, M. Guerrero, and T. Compton Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells J Immunol 177 2006 7094 7102
82. V.R. DeFilippis, D. Alvarado, T. Sali, S. Rothenburg, and K. Fruh Human cytomegalovirus induces the interferon response via the DNA sensor ZBP1 J Virol 84 2010 585 598
83. V.R. DeFilippis, T. Sali, D. Alvarado, L. White, W. Bresnahan, and K.J. Fruh Activation of the interferon response by human cytomegalovirus occurs via cytoplasmic double-stranded DNA but not glycoprotein B J Virol 84 2010 8913 8925
84. K.H. Yew, C. Carpenter, R.S. Duncan, and C.J. Harrison Human cytomegalovirus induces TLR4 signaling components in monocytes altering TIRAP, TRAM and downstream interferon-beta and TNF-alpha expression PLoS One 7 2012 e44500
85. S. Kuenzel, A. Till, M. Winkler, R. Hasler, S. Lipinski, S. Jung, J. Grotzinger, H. Fickenscher, S. Schreiber, and P. Rosenstiel The nucleotide-binding oligomerization domain-like receptor NLRC5 is involved in IFN-dependent antiviral immune responses J Immunol 184 2010 1990 2000
86. S. Ning, J.S. Pagano, and G.N. Barber IRF7: activation, regulation, modification and function Genes Immun 12 2011 399 414
87. S.Y. Liu, D.J. Sanchez, and G. Cheng New developments in the induction and antiviral effectors of type I interferon Curr Opin Immunol 23 2011 57 64
88. A.J. Sadler, and B.R. Williams Interferon-inducible antiviral effectors Nat Rev Immunol 8 2008 559 568
89. M.J. de Veer, M. Holko, M. Frevel, E. Walker, S. Der, J.M. Paranjape, R.H. Silverman, and B.R. Williams Functional classification of interferon-stimulated genes identified using microarrays J Leukoc Biol 69 2001 912 920
90. E. Meurs, K. Chong, J. Galabru, N.S. Thomas, I.M. Kerr, B.R. Williams, and A.G. Hovanessian Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon Cell 62 1990 379 390
91. A. Zhou, J. Paranjape, T.L. Brown, H. Nie, S. Naik, B. Dong, A. Chang, B. Trapp, R. Fairchild, C. Colmenares, and R.H. Silverman Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L EMBO J 16 1997 6355 6363
92. M. Yoneyama, M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, M. Miyagishi, K. Taira, S. Akira, and T. Fujita The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses Nat Immunol 5 2004 730 737
93. R.B. Seth, L. Sun, and Z.J. Chen Antiviral innate immunity pathways Cell Res 16 2006 141 147
94. R.B. Seth, L. Sun, C.K. Ea, and Z.J. Chen Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-kappaB and IRF3 Cell 122 2005 669 682
95. V.A. Rathinam, Z. Jiang, S.N. Waggoner, S. Sharma, L.E. Cole, L. Waggoner, S.K. Vanaja, B.G. Monks, S. Ganesan, E. Latz, V. Hornung, S.N. Vogel, E. Szomolanyi-Tsuda, and K.A. Fitzgerald The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses Nat Immunol 11 2010 395 402
96. K.C. Chin, and P. Cresswell Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus Proc Natl Acad Sci U S A 98 2001 15125 15130
97. M.S. Diamond, and M. Farzan The broad-spectrum antiviral functions of IFIT and IFITM proteins Nat Rev Immunol 13 2013 46 57
98. C. Zhao, M.N. Collins, T.Y. Hsiang, and R.M. Krug Interferon-induced ISG15 pathway: an ongoing virus-host battle Trends Microbiol 21 2013 181 186
99. C. Paulus, S. Krauss, and M. Nevels A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling Proc Natl Acad Sci U S A 103 2006 3840 3845
100. D.M. Miller, Y. Zhang, B.M. Rahill, W.J. Waldman, and D.D. Sedmak Human cytomegalovirus inhibits IFN-alpha-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-alpha signal transduction J Immunol 162 1999 6107 6113
101. D.M. Miller, B.M. Rahill, J.M. Boss, M.D. Lairmore, J.E. Durbin, J.W. Waldman, and D.D. Sedmak Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway J Exp Med 187 1998 675 683
102. M. Baron, and J.L. Davignon Inhibition of IFN-gamma-induced STAT1 tyrosine phosphorylation by human CMV is mediated by SHP2 J Immunol 181 2008 5530 5536
103. M. You, D.H. Yu, and G.S. Feng Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway Mol Cell Biol 19 1999 2416 2424
104. A. Zimmermann, M. Trilling, M. Wagner, M. Wilborn, I. Bubic, S. Jonjic, U. Koszinowski, and H. Hengel A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses J Exp Med 201 2005 1543 1553
105. S. Krauss, J. Kaps, N. Czech, C. Paulus, and M. Nevels Physical requirements and functional consequences of complex formation between the cytomegalovirus IE1 protein and human STAT2 J Virol 83 2009 12854 12870
106. F. Korioth, G.G. Maul, B. Plachter, T. Stamminger, and J. Frey The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1 Exp Cell Res 229 1996 155 158
107. Y.H. Huh, Y.E. Kim, E.T. Kim, J.J. Park, M.J. Song, H. Zhu, G.S. Hayward, and J.H. Ahn Binding STAT2 by the acidic domain of human cytomegalovirus IE1 promotes viral growth and is negatively regulated by SUMO J Virol 82 2008 10444 10454
108. T. Knoblach, B. Grandel, J. Seiler, M. Nevels, and C. Paulus Human cytomegalovirus IE1 protein elicits a type II interferon-like host cell response that depends on activated STAT1 but not interferon-gamma PLoS Pathog 7 2011 e1002016
109. G.A. Versteeg, and A. Garcia-Sastre Viral tricks to grid-lock the type I interferon system Curr Opin Microbiol 13 2010 508 516
110. R.T. Taylor, and W.A. Bresnahan Human cytomegalovirus immediate-early 2 gene expression blocks virus-induced beta interferon production J Virol 79 2005 3873 3877
111. R.T. Taylor, and W.A. Bresnahan Human cytomegalovirus immediate-early 2 protein IE86 blocks virus-induced chemokine expression J Virol 80 2006 920 928
112. S.M. Varnum, D.N. Streblow, M.E. Monroe, P. Smith, K.J. Auberry, L. Pasa-Tolic, D. Wang, D.G. Camp 2nd, K. Rodland, S. Wiley, W. Britt, T. Shenk, R.D. Smith, and J.A. Nelson Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome J Virol 78 2004 10960 10966
113. J. Odeberg, B. Plachter, L. Branden, and C. Soderberg-Naucler Human cytomegalovirus protein pp 65 mediates accumulation of HLA-DR in lysosomes and destruction of the HLA-DR alpha-chain Blood 101 2003 4870 4877
114. T.I. Arnon, H. Achdout, O. Levi, G. Markel, N. Saleh, G. Katz, R. Gazit, T. Gonen-Gross, J. Hanna, E. Nahari, A. Porgador, A. Honigman, B. Plachter, D. Mevorach, D.G. Wolf, and O. Mandelboim Inhibition of the NKp30 activating receptor by pp 65 of human cytomegalovirus Nat Immunol 6 2005 515 523
115. I.M. Cristea, N.J. Moorman, S.S. Terhune, C.D. Cuevas, E.S. O'Keefe, M.P. Rout, B.T. Chait, and T. Shenk Human cytomegalovirus pUL83 stimulates activity of the viral immediate-early promoter through its interaction with the cellular IFI16 protein J Virol 84 2010 7803 7814
116. S. Pestka, C.D. Krause, D. Sarkar, M.R. Walter, Y. Shi, and P.B. Fisher Interleukin-10 and related cytokines and receptors Annu Rev Immunol 22 2004 929 979
117. S.V. Kotenko, S. Saccani, L.S. Izotova, O.V. Mirochnitchenko, and S. Pestka Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10) Proc Natl Acad Sci U S A 97 2000 1695 1700
118. B.C. Jones, N.J. Logsdon, K. Josephson, J. Cook, P.A. Barry, and M.R. Walter Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1 Proc Natl Acad Sci U S A 99 2002 9404 9409
119. W.L. Chang, and P.A. Barry Attenuation of innate immunity by cytomegalovirus IL-10 establishes a long-term deficit of adaptive antiviral immunity Proc Natl Acad Sci U S A 107 2010 22647 22652
120. W.L. Chang, P.A. Barry, R. Szubin, D. Wang, and N. Baumgarth Human cytomegalovirus suppresses type I interferon secretion by plasmacytoid dendritic cells through its interleukin 10 homolog Virology 390 2009 330 337
121. M. Munir, and M. Berg The multiple faces of proteinkinase R in antiviral defense Virulence 4 2013 85 89
122. E.E. Marshall, C.J. Bierle, W. Brune, and A.P. Geballe Essential role for either TRS1 or IRS1 in human cytomegalovirus replication J Virol 83 2009 4112 4120
123. S.J. Child, S. Jarrahian, V.M. Harper, and A.P. Geballe Complementation of vaccinia virus lacking the double-stranded RNA-binding protein gene E3L by human cytomegalovirus J Virol 76 2002 4912 4918
124. S.J. Child, M. Hakki, K.L. De Niro, and A.P. Geballe Evasion of cellular antiviral responses by human cytomegalovirus TRS1 and IRS1 J Virol 78 2004 197 205
125. K.A. Cassady Human cytomegalovirus TRS1 and IRS1 gene products block the double-stranded-RNA-activated host protein shutoff response induced by herpes simplex virus type 1 infection J Virol 79 2005 8707 8715
126. W. Dunn, C. Chou, H. Li, R. Hai, D. Patterson, V. Stolc, H. Zhu, and F. Liu Functional profiling of a human cytomegalovirus genome Proc Natl Acad Sci U S A 100 2003 14223 14228
127. C.A. Blankenship, and T. Shenk Mutant human cytomegalovirus lacking the immediate-early TRS1 coding region exhibits a late defect J Virol 76 2002 12290 12299
128. T.R. Jones, and V.P. Muzithras A cluster of dispensable genes within the human cytomegalovirus genome short component: IRS1, US1 through US5, and the US6 family J Virol 66 1992 2541 2546
129. M. Hakki, and A.P. Geballe Double-stranded RNA binding by human cytomegalovirus pTRS1 J Virol 79 2005 7311 7318
130. M. Hakki, E.E. Marshall, K.L. De Niro, and A.P. Geballe Binding and nuclear relocalization of protein kinase R by human cytomegalovirus TRS1 J Virol 80 2006 11817 11826
131. C.J. Bierle, K.M. Semmens, and A.P. Geballe Double-stranded RNA binding by the human cytomegalovirus PKR antagonist TRS1 Virology 442 2013 28 37
132. A. Peisley, and S. Hur Multi-level regulation of cellular recognition of viral dsRNA Cell Mol Life Sci 70 2013 1949 1963
133. J.C. Tan, S. Avdic, J.Z. Cao, E.S. Mocarski, K.L. White, A. Abendroth, and B. Slobedman Inhibition of 2',5'-oligoadenylate synthetase expression and function by the human cytomegalovirus ORF94 gene product J Virol 85 2011 5696 5700
134. Y.H. Chiu, J.B. Macmillan, and Z.J. Chen RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway Cell 138 2009 576 591
135. I. Scott, and K.L. Norris The mitochondrial antiviral signaling protein, MAVS, is cleaved during apoptosis Biochem Biophys Res Commun 375 2008 101 106
136. M. Rebsamen, E. Meylan, J. Curran, and J. Tschopp The antiviral adaptor proteins Cardif and Trif are processed and inactivated by caspases Cell Death Differ 15 2008 1804 1811
137. X.D. Li, L. Sun, R.B. Seth, G. Pineda, and Z.J. Chen Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity Proc Natl Acad Sci U S A 102 2005 17717 17722
138. V.S. Goldmacher, L.M. Bartle, A. Skaletskaya, C.A. Dionne, N.L. Kedersha, C.A. Vater, J.W. Han, R.J. Lutz, S. Watanabe, E.D. Cahir McFarland, E.D. Kieff, E.S. Mocarski, and T. Chittenden A cytomegalovirus-encoded mitochondria- localized inhibitor of apoptosis structurally unrelated to Bcl-2 Proc Natl Acad Sci U S A 96 1999 12536 12541
139. A. Skaletskaya, L.M. Bartle, T. Chittenden, A.L. McCormick, E.S. Mocarski, and V.S. Goldmacher A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation Proc Natl Acad Sci U S A 98 2001 7829 7834
140. I. Scott Degradation of RIG-I following cytomegalovirus infection is independent of apoptosis Microbes Infect 11 2009 973 979
141. S. Veeranki, and D. Choubey Interferon-inducible p200-family protein IFI16, an innate immune sensor for cytosolic and nuclear double-stranded DNA: Regulation of subcellular localization Mol Immunol 49 2012 567 571
142. L. Unterholzner, S.E. Keating, M. Baran, K.A. Horan, S.B. Jensen, S. Sharma, C.M. Sirois, T. Jin, E. Latz, T.S. Xiao, K.A. Fitzgerald, S.R. Paludan, and A.G. Bowie IFI16 is an innate immune sensor for intracellular DNA Nat Immunol 11 2010 997 1004
143. G.R. Gariano, V. Dell'Oste, M. Bronzini, D. Gatti, A. Luganini, M. De Andrea, G. Gribaudo, M. Gariglio, and S. Landolfo The intracellular DNA sensor IFI16 gene acts as restriction factor for human cytomegalovirus replication PLoS Pathog 8 2012 e1002498
144. W. Cao, L. Bover, M. Cho, X. Wen, S. Hanabuchi, M. Bao, D.B. Rosen, Y.H. Wang, J.L. Shaw, Q. Du, C. Li, N. Arai, Z. Yao, L.L. Lanier, and Y.J. Liu Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction J Exp Med 206 2009 1603 1614
145. A.L. Blasius, E. Giurisato, M. Cella, R.D. Schreiber, A.S. Shaw, and M. Colonna Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation J Immunol 177 2006 3260 3265
146. T. Goto, S.J. Kennel, M. Abe, M. Takishita, M. Kosaka, A. Solomon, and S. Saito A novel membrane antigen selectively expressed on terminally differentiated human B cells Blood 84 1994 1922 1930
147. S.J. Neil The antiviral activities of tetherin Curr Top Microbiol Immunol 371 2013 67 104
148. J.L. Douglas, J.K. Gustin, K. Viswanathan, M. Mansouri, A.V. Moses, and K. Fruh The great escape: viral strategies to counter BST-2/tetherin PLoS Pathog 6 2010 e1000913
149. M. Mansouri, K. Viswanathan, J.L. Douglas, J. Hines, J. Gustin, A.V. Moses, and K. Fruh Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus J Virol 83 2009 9672 9681
150. K. Viswanathan, M.S. Smith, D. Malouli, M. Mansouri, J.A. Nelson, and K. Fruh BST2/Tetherin enhances entry of human cytomegalovirus PLoS Pathog 7 2011 e1002332
151. M. Reeves, and J. Sinclair Aspects of Human Cytomegalovirus Latency and Reactivation T. Shenk, M.F. Stinski, Current Topics in Microbiology and Immunology vol. 325 2008 297 313
152. J.Y. Seo, R. Yaneva, E.R. Hinson, and P. Cresswell Human cytomegalovirus directly induces the antiviral protein viperin to enhance infectivity Science 332 2011 1093 1097
153. S. Mattijssen, and G.J. Pruijn Viperin, a key player in the antiviral response Microbes Infect 14 2012 419 426
154. D. Poncet, A.L. Pauleau, G. Szabadkai, A. Vozza, S.R. Scholz, M. Le Bras, J.J. Briere, A. Jalil, R. Le Moigne, C. Brenner, G. Hahn, I. Wittig, H. Schagger, C. Lemaire, K. Bianchi, S. Souquere, G. Pierron, P. Rustin, V.S. Goldmacher, R. Rizzuto, F. Palmieri, and G. Kroemer Cytopathic effects of the cytomegalovirus-encoded apoptosis inhibitory protein vMIA J Cell Biol 174 2006 985 996
155. A.E. Reynolds, and L.W. Enquist Biological interactions between herpesviruses and cyclooxygenase enzymes Rev Med Virol 16 2006 393 403
156. W.L. Smith, D.L. DeWitt, and R.M. Garavito Cyclooxygenases: structural, cellular, and molecular biology Annu Rev Biochem 69 2000 145 182
157. H. Zhu, J.P. Cong, D. Yu, W.A. Bresnahan, and T.E. Shenk Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication Proc Natl Acad Sci U S A 99 2002 3932 3937
158. J. Schroer, and T. Shenk Inhibition of cyclooxygenase activity blocks cell-to-cell spread of human cytomegalovirus Proc Natl Acad Sci U S A 105 2008 19468 19473
159. C.A. Rue, M.A. Jarvis, A.J. Knoche, H.L. Meyers, V.R. DeFilippis, S.G. Hansen, M. Wagner, K. Fruh, D.G. Anders, S.W. Wong, P.A. Barry, and J.A. Nelson A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism J Virol 78 2004 12529 12536
160. S. Basta, and J.R. Bennink A survival game of hide and seek: cytomegaloviruses and MHC class I antigen presentation pathways Viral Immunol 16 2003 231 242